ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Clinical Cardiac Electrophysiology

Top Clinical Cardiac Electrophysiology Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
FANIA SAMUELS MD

Clinical Cardiac Electrophysiology

17,827

$1.31M

764
715 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 26%

$74
Average prescription price

Avg: $73

DINA YAZMAJIAN M.D.

Clinical Cardiac Electrophysiology

3,921

$200K

322
298 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $73

RICHARD BORGE M.D.

Clinical Cardiac Electrophysiology

3,878

$236K

352
331 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $73

TATJANA SLJAPIC M.D.

Clinical Cardiac Electrophysiology

3,710

$169K

504
440 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 26%

$45
Average prescription price

Avg: $73

KELLY HAYES MD

Clinical Cardiac Electrophysiology

3,449

$230K

460
402 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 26%

$67
Average prescription price

Avg: $73

DANIEL CONTRAFATTO M.D.

Clinical Cardiac Electrophysiology

2,873

$146K

292
263 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $73

JEAN MOUBARAK MD

Clinical Cardiac Electrophysiology

2,859

$178K

372
322 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 26%

$62
Average prescription price

Avg: $73

KOROUSH KHALIGHI M.D.

Clinical Cardiac Electrophysiology

2,851

$206K

281
251 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 26%

$72
Average prescription price

Avg: $73

JOHN LUNDIN M.D.

Clinical Cardiac Electrophysiology

2,469

$130K

218
193 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 26%

$53
Average prescription price

Avg: $73

GUR ADHAR M.D.

Clinical Cardiac Electrophysiology

2,169

$109K

238
213 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $73

KAR LAI WONG M.D.

Clinical Cardiac Electrophysiology

2,167

$118K

187
166 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $73

FREDERICK PORKOLAB MD

Clinical Cardiac Electrophysiology

2,121

$183K

319
271 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 26%

$86
Average prescription price

Avg: $73

HOPE HELFELD DO

Clinical Cardiac Electrophysiology

1,939

$137K

352
322 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 26%

$71
Average prescription price

Avg: $73

RICHARD HUI M.D.

Clinical Cardiac Electrophysiology

1,935

$132K

201
188 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 26%

$68
Average prescription price

Avg: $73

MELISSA MCKERNAN PULLIAM M.D.

Clinical Cardiac Electrophysiology

1,886

$144K

337
306 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 26%

$76
Average prescription price

Avg: $73

VITALY GEYFMAN D.O.

Clinical Cardiac Electrophysiology

1,886

$65.9K

169
143 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 26%

$35
Average prescription price

Avg: $73

CHRISTOPHER SCHULZE DO

Clinical Cardiac Electrophysiology

1,853

$127K

299
255 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 26%

$68
Average prescription price

Avg: $73

COLIN MOVSOWITZ MD

Clinical Cardiac Electrophysiology

1,815

$140K

193
172 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 26%

$77
Average prescription price

Avg: $73

SETH WORLEY M.D.

Clinical Cardiac Electrophysiology

1,791

$248K

318
302 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 26%

$139
Average prescription price

Avg: $73

DOUGLAS GOHN M.D.

Clinical Cardiac Electrophysiology

1,774

$211K

297
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 26%

$119
Average prescription price

Avg: $73

MATTHEW BERNABEI M.D.

Clinical Cardiac Electrophysiology

1,759

$172K

386
347 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 26%

$98
Average prescription price

Avg: $73

BRIAN SCHULER MD

Clinical Cardiac Electrophysiology

1,639

$125K

336
301 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 26%

$76
Average prescription price

Avg: $73

VADIM LEVIN M.D.

Clinical Cardiac Electrophysiology

1,573

$176K

173
153 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 26%

$112
Average prescription price

Avg: $73

ROBERT MALACOFF MD

Clinical Cardiac Electrophysiology

1,555

$74.8K

161
146 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $73

MICHAEL SABADISH M.D.

Clinical Cardiac Electrophysiology

1,547

$73K

165
152 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 26%

$47
Average prescription price

Avg: $73

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank